Company news
Beijing Balance Medical Technology Co. Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
(688198)"Beijing Balance Medical Technology Co., Ltd."Report for Q3 2026
October 28, 2026
(688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Appointment of Securities Affairs Representative
October 28, 2026
(688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure Regarding the Entry of the Minimally Invasive Pre-positionable Sutureless Aortic Valve System into the Special Review Procedure for Innovative Medical Devices
October 19, 2026
(688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure of Entry of ePTFE Pulmonary Artery Valved Conduit into the Special Review Procedure for Innovative Medical Devices
October 16, 2026
(688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Vesting Results for the 4th Vesting Period of the Reserved Grant under the 2020 Restricted Share Incentive Plan and Listing of Shares
October 15, 2026
(688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure of the Approval for Registration of the Innovative Product Transcatheter Pulmonary Valve System
October 12, 2026
Announcement on Implementation Results of Share Repurchase
September 30, 2026
Announcement on Voluntary Disclosure of the Approval for Registration of the Innovative Product, Valved Patch for Complex Congenital Heart Disease
September 23, 2026
Announcement on Voluntary Disclosure of the Aortic Root Enlargement Patch Entering the Special Review Procedure for Innovative Medical Devices
September 14, 2026
Announcement on Voluntary Disclosure of the Failure to Obtain Approval for the Registration Application for Ophthalmic Surgical Biological Patch
September 4, 2026
Semi-annual Report for 2026
August 26, 2026
Announcement on Convening the 2026 Semi-annual Performance Briefing
August 24, 2026
Announcement on Progress in Repurchasing Shares through Call Auction
August 3, 2026
Announcement on the Voluntary Disclosure of the Approval for Registration of the Subsidiary's Cross-Linked Collagen Implant Product (Collagen Fiber Filler-II)
July 22, 2026
Announcement on Canceling Certain Restricted Stock Granted but Not Yet Vested for 2020
July 17, 2026
Announcement on the Opening of an Additional Securities Account for Share Repurchase
July 10, 2026
Announcement on Increasing Sources of Funds for Share Repurchase and Receiving Commitment Letter for Special Loan for Share Repurchase
July 7, 2026
Announcement on Progress in Repurchasing Shares through Call Auction
July 1, 2026
Announcement on Voluntary Disclosure of the Registration Approval of the Anastomotic Reinforcement and Repair Patch (Biological Patch for Digestive Surgery) Product
June 21, 2026
Announcement on Initially Repurchasing the Company's Shares through Call Auction
June 17, 2026
Announcement on Shareholding of Top 10 Shareholders and Top 10 Holders of Shares Without Sales Limit Concerning Shares Repurchase
June 11, 2026
Scheme for Repurchasing Shares through Call Auction
June 10, 2026
Announcement on Implementation of Dividend Distribution for 2025
May 19, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 12, 2026
Announcement on the Resignation of Core Technical Personnel
May 7, 2026
Notice on Convening the 2025 Annual General Meeting
April 21, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
Announcement on Voluntary Disclosure of the Approval and Registration of Subsidiary’s Collagen Implant Products
December 11, 2025
Announcement on the Voluntary Disclosure of ePTFE Pericardial Membrane Product Registration Approval
December 3, 2025
Report for Q3 2025
October 30, 2025
Announcement on Adjustment of Directors and Election of Employee Representative Directors for the 3rd Board of Directors
September 25, 2025
Announcement on Voluntary Disclosure of Entry of RF Ablation System into Special Review Procedure for Innovative Medical Devices
September 23, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
September 16, 2025
2025 Semi-annual Report
August 27, 2025
Announcement on Voluntary Disclosure of Acceptance of Registration Application for Patent Foramen Ovale Occluder
August 18, 2025
Announcement on Vesting Results of the 5th Vesting Period of Those Initially Granted and the 3rd Vesting Period of Those Reserved for Grant in 2020 Restricted Stock Incentive Plan and Listing of Shares
July 24, 2025
Announcement on Cancellation of Some 2020 Restricted Stocks Granted but Not Vested
June 13, 2025
Announcement on Voluntary Disclosure of Acceptance of Registration Application for Gastrointestinal Surgery Biological Mesh
May 23, 2025
Announcement on Implementation of Dividend Distribution for 2024
May 22, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 15, 2025
Report for Q1 2025
April 24, 2025
Announcement on Progress in Bidding for Land Use Rights and Investing in Construction Projects
April 2, 2025
Announcement on Results of Share Increase by Controlling Shareholder and Actual Controller
March 26, 2025
Announcement on Voluntary Disclosure of the Acceptance of the Registration Application for the Interventional Pulmonary Valve and Delivery System
March 7, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 25, 2025
Announcement on Proposing to Purchase Land Use Rights and Invest in Construction Projects
February 11, 2025
Announcement on Voluntary Disclosure of Interventional Pulmonary Valve and Delivery System Entering the Special Review Procedure for Innovative Medical Devices
January 3, 2025
Announcement on Voluntary Disclosure of Acceptance of Registration Application for Ophthalmological Biological Mesh
November 28, 2024
Announcement on Voluntary Disclosure of Acceptance of Registration Application for Pericardium
November 19, 2024
Announcement on Convening the Q3 2024 Performance Briefing
October 29, 2024